EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farese, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farese, R. V.
Experimental Biology and Medicine 226:283-295 (2001)
© 2001 Society for Experimental Biology and Medicine

MINIREVIEW

Insulin-Sensitive Phospholipid Signaling Systems and Glucose Transport. Update II1

Robert V. Farese,2

J.A. Haley Veterans' Hospital Research Service and Department of Internal Medicine, University of South Florida College of Medicine, Tampa, Florida33612

Insulin provokes rapid changes in phospholipid metabolism and thereby generates biologically active lipids that serve as intracellular signaling factors that regulate glucose transport and glycogen synthesis. These changes include: (i) activation of phosphatidylinositol 3-kinase (PI3K) and production of PIP3; (ii) PIP3-dependent activation of atypical protein kinase Cs (PKCs); (iii) PIP3-dependent activation of PKB; (iv) PI3K-dependent activation of phospholipase D and hydrolysis of phosphatidylcholine with subsequent increases in phosphatidic acid (PA) and diacylglycerol (DAG); (v) PI3K-independent activation of glycerol-3-phosphate acylytansferase and increases in de novo synthesis of PA and DAG; and (vi) activation of DAG-sensitive PKCs. Recent findings suggest that atypical PKCs and PKB serve as important positive regulators of insulin-stimulated glucose metabolism, whereas mechanisms that result in the activation of DAG-sensitive PKCs serve mainly as negative regulators of insulin signaling through PI3K. Atypical PKCs and PKB are rapidly activated by insulin in adipocytes, liver, skeletal muscles, and other cell types by a mechanism requiring PI3K and its downstream effector, 3-phosphoinositide-dependent protein kinase-1 (PDK-1), which, in conjunction with PIP3, phosphorylates critical threonine residues in the activation loops of atypical PKCs and PKB. PIP3 also promotes increases in autophosphorylation and allosteric activation of atypical PKCs. Atypical PKCs and perhaps PKB appear to be required for insulin-induced translocation of the GLUT 4 glucose transporter to the plasma membrane and subsequent glucose transport. PKB also appears to be the major regulator of glycogen synthase. Together, atypical PKCs and PKB serve as a potent, integrated PI3K/PDK-1-directed signaling system that is used by insulin to regulate glucose metabolism.

Key Words: insulin • glucose transport • atypical protein kinase C • protein kinase C-{zeta}/{lambda} • protein kinase B • inositol phospholipids • polyphosphoinositides




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
X. X. Yu, S. K. Pandey, S. L. Booten, S. F. Murray, B. P. Monia, and S. Bhanot
Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E530 - E539.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Fauconnier, J. T. Lanner, A. Sultan, S.-J. Zhang, A. Katz, J. D. Bruton, and H. Westerblad
Insulin potentiates TRPC3-mediated cation currents in normal but not in insulin-resistant mouse cardiomyocytes
Cardiovasc Res, January 15, 2007; 73(2): 376 - 385.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. D. Labonte, R. J. Kirby, N. M. Schildmeyer, A. M. Cannon, K. W. Huggins, and D. Y. Hui
Group 1B Phospholipase A2-Mediated Lysophospholipid Absorption Directly Contributes to Postprandial Hyperglycemia.
Diabetes, April 1, 2006; 55(4): 935 - 941.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. A. Hornberger, W. K. Chu, Y. W. Mak, J. W. Hsiung, S. A. Huang, and S. Chien
The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle
PNAS, March 21, 2006; 103(12): 4741 - 4746.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. S. Hutchinson and T. Bengtsson
{alpha}1A-Adrenoceptors Activate Glucose Uptake in L6 Muscle Cells through a Phospholipase C-, Phosphatidylinositol-3 Kinase-, and Atypical Protein Kinase C-Dependent Pathway
Endocrinology, February 1, 2005; 146(2): 901 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
X. Cao, F. Kambe, L. C. Moeller, S. Refetoff, and H. Seo
Thyroid Hormone Induces Rapid Activation of Akt/Protein Kinase B-Mammalian Target of Rapamycin-p70S6K Cascade through Phosphatidylinositol 3-Kinase in Human Fibroblasts
Mol. Endocrinol., January 1, 2005; 19(1): 102 - 112.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. K. Kim, K. J. Woodcroft, S. S. Khodadadeh, and R. F. Novak
Insulin Signaling Regulates {gamma}-Glutamylcysteine Ligase Catalytic Subunit Expression in Primary Cultured Rat Hepatocytes
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 99 - 108.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
K. A. Webster
Aktion in the Nucleus
Circ. Res., April 16, 2004; 94(7): 856 - 859.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. E. Fagan, C. Cefaratti, and A. Romani
Streptozotocin-induced diabetes impairs Mg2+ homeostasis and uptake in rat liver cells
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E184 - E193.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Perrini, J. Henriksson, J. R. Zierath, and U. Widegren
Exercise-Induced Protein Kinase C Isoform-Specific Activation in Human Skeletal Muscle
Diabetes, January 1, 2004; 53(1): 21 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. Zimmermann, G. Haemmerle, E. M. Wagner, J. G. Strauss, D. Kratky, and R. Zechner
Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue
J. Lipid Res., November 1, 2003; 44(11): 2089 - 2099.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. K. Kim, K. J. Woodcroft, S. G. Kim, and R. F. Novak
INSULIN AND GLUCAGON SIGNALING IN REGULATION OF MICROSOMAL EPOXIDE HYDROLASE EXPRESSION IN PRIMARY CULTURED RAT HEPATOCYTES
Drug Metab. Dispos., October 1, 2003; 31(10): 1260 - 1268.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
W. L. Holland, E. C. Stauter, and B. J. Stith
Quantification of phosphatidic acid and lysophosphatidic acid by HPLC with evaporative light-scattering detection
J. Lipid Res., April 1, 2003; 44(4): 854 - 858.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
N. Kumar and C. S. Dey
Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells
J. Exp. Biol., December 1, 2002; 205(23): 3739 - 3746.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. C. Chen, S. J. Stone, P. Zhou, K. K. Buhman, and R. V. Farese Jr
Dissociation of Obesity and Impaired Glucose Disposal in Mice Overexpressing Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 in White Adipose Tissue
Diabetes, November 1, 2002; 51(11): 3189 - 3195.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. F. P. Wojtaszewski, J. N. Nielsen, and E. A. Richter
Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Effect of acute exercise on insulin signaling and action in humans
J Appl Physiol, July 1, 2002; 93(1): 384 - 392.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Experimental Biology and Medicine.